Rheological alterations and thrombotic events in patients with systemic lupus erythematosus

被引:13
|
作者
Vaya, Amparo [1 ]
Calvo, Javier [2 ]
Alcala, Carmen [1 ]
Mico, Luisa [3 ]
Todoli, Jose [3 ]
Ricart, Jose M. [4 ]
机构
[1] La Fe Univ Hosp, Hemorheol & Hemostasis Unit, Serv Clin Pathol, Valencia 46009, Spain
[2] Gen Hosp, Rheumatol Serv, Valencia, Spain
[3] La Fe Univ Hosp, Internal Med Serv, Valencia 46009, Spain
[4] La Fe Univ Hosp, Dermatol Serv, Valencia 46009, Spain
关键词
Systemic lupus erythematosus; thrombosis; hemorheology; WHOLE-BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; PLASMA;
D O I
10.3233/CH-2011-1508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is characterised by increased venous and arterial thrombotic risk. Nevertheless, how hemorheological alterations contribute to thrombotic risk remains a question of debate. We aimed to determine the rheological profile in 105 patients with SLE (24 with a thrombotic event) and 105 healthy controls. We determined blood viscosity and erythrocyte aggregation along with plasma lipids and fibrinogen. Although SLE patients showed lower blood viscosity at 230 s(-1) at a native hematocrit when compared with controls (p < 0.001), differences disappeared after adjusting the hematocrit to 45% (p = 0.095). When comparing SLE patients with and without thrombotic events, no differences in any rheological parameter were found (p > 0.05), except in fibrinogen which was higher in patients with thrombosis (p = 0.013). No differences in the rheological parameters were observed when venous and arterial thrombotic events were compared, although a tendency for higher fibrinogen was observed in patients with venous thrombosis (p = 0.053). Only hematocrit, fibrinogen and triglycerides were independent predictors of native blood viscosity in the multivariate regression analysis, even after adjusting for continuous variables and for tobacco and hypertension: beta coefficient: 0.727 p < 0.001; beta coefficient: 0.152 p = 0.003 and beta coefficient: 0.133 p = 0.015, respectively. The logistic regression analysis revealed that neither increased native blood viscosity (BVn > 4.33) nor increased erythrocyte aggregation (EA1 > 7.85) increased thrombotic risk: OR 0.636, CI 0.313-3.12, p = 0.578 and OR 2.01, CI 0.77-5.20, p = 0.152, respectively. However, hyperfibrinogenemia (Fbg > 342 mg/dL) increased thrombotic risk by around three times: OR 3.44 CI 1.32-8.96, p = 0.011. Our results suggest that the role of blood viscosity and erythrocyte aggregation in thrombotic risk in SLE patients fails to demonstrate any association.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [41] Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis
    Shahin, AA
    Mostafa, H
    Sami, H
    Shahin, HA
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (03): : 246 - 250
  • [42] Outcome of Patients with Systemic Lupus Erythematous (SLE) after Thrombotic Events
    Alharbi, Samar
    Su, Jiandong
    Morrison, Stacey E.
    Attar, Mohammed
    Al-Ghanim, Khawla
    Urowitz, Murray
    Gladman, Dafna
    Sanchez-Guerrero, Jorge
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] PREDICTIVE THROMBOTIC VALUE OF LUPUS ANTICOAGULANT AND ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    FERRO, D
    QUINTARELLI, C
    BASILI, S
    PITTONI, V
    CARA, D
    VALESINI, G
    VIOLI, F
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1274 - 1274
  • [44] Systemic Lupus Erythematosus Presented by Thrombotic Thrombocytopenic A Case
    Elshweikh, Samah A.
    Aldubaikhi, Abdurahman
    Albaybi, Sultan
    Alsedrani, Rayan
    Alqahtani, Asayel
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2023, 13 (01): : L307 - L311
  • [45] About systemic lupus erythematosus and thrombotic thrombocytopenic purpura
    Durand, JM
    LUPUS, 1998, 7 (04) : 235 - 235
  • [46] Thrombotic Thrombocytopenic Purpura in a Child With Systemic Lupus Erythematosus
    Thampi, Sheila
    Salmi, Darren
    Imashuku, Shinsaku
    Ducore, Jonathan
    Satake, Noriko
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (03) : 221 - 223
  • [47] SYSTEMIC LUPUS-ERYTHEMATOSUS AND THROMBOCYTOPENIC THROMBOTIC PURPURA
    ROCATEY, R
    FORT, J
    ANGLES, R
    PALOMAR, M
    MEDICINA CLINICA, 1994, 102 (02): : 75 - 76
  • [48] Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Efficacy of Eculizumab
    El-Husseini, Amr
    Hannan, Schot
    Awad, Ahmed
    Jennings, Stuart
    Cornea, Virgilius
    Sawaya, B. Peter
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (01) : 127 - 130
  • [49] THROMBOTIC THROMBOCYTOPENIC PURPURA AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    FOX, DA
    FAIX, JD
    COBLYN, J
    FRASER, P
    SMITH, B
    WEINBLATT, ME
    ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (04) : 319 - 322
  • [50] A case of thrombotic microangiopathy complicated with systemic lupus erythematosus
    Ohashi, N
    Yamamoto, T
    Kanno, D
    Fujigaki, Y
    Yonemura, K
    Hishida, A
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 326 (02): : 102 - 104